Premium
Private equity firm The Carlyle Group is evaluating a Hyderabad-based bulk-drugs maker as part of its plan to build an investment platform in this segment, two people with knowledge of the matter told VCCircle. The PE firm is checking out Symed Labs Ltd to see if the company would fit into ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
